Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cardiac myosin heavy chain is a critical protein component of the contractile apparatus in heart muscle cells. It exists primarily as two isoforms in humans: alpha (α) and beta (β), encoded by the MYH6 and MYH7 genes, respectively. The β-myosin heavy chain is predominant in human ventricular myocardium, while α-myosin heavy chain is more abundant in atrial tissue. Cardiac myosin acts as a molecular motor converting chemical energy from ATP hydrolysis into mechanical force for heart contraction. Mutations or altered expression patterns of cardiac myosin heavy chains are implicated in various cardiomyopathies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin Heavy Chain (Cardiac).